Symbol
CRSP on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Shares Owned
1,186,794 shares
Security Ownership %
1.2%
Shares, Excluding Options vs Price
Value, Excluding Options

Capital International Investors ownership in CRISPR Therapeutics AG Common Stock (CRSP)

05 Feb 2026 - Capital International Investors has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,186,794 shares of CRISPR Therapeutics AG Common Stock (CRSP). This represents 1.2% ownership of the company. In their previous filing dated 13 May 2025, Capital International Investors had reported owning 6,334,142 shares, indicating a decrease of +81%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.